The Max-Delbrueck Center for Molecular Medicine (MDC) is a research institute within the Helmholtz Association that also holds AS210482. Public PeeringDB and website evidence confirm the ASN registration, but no prefix announcements are observed, making its network role dormant. The primary significance lies in the potential for future routing activity, which would necessitate updated infrastructure risk and dependency assessments. Watchpoints include ASN status changes, new prefixes, and upstream provider disclosures. Current evidence is limited to the registry entry and the institute's own website, leaving its actual network integration and commercial contracts uncertain.
The center is visible in global internet resource registries through its ASN, but it does not currently advertise any IP prefixes. Its network operating role is therefore inactive or operated behind transit, making the registry entry the primary public evidence of its potential for future routing activity.
Changes in the center's registry status or the appearance of announced prefixes would signal shifts in its network operations, connectivity, or exposure. As a biomedical research hub, any network activation could affect dependency chains within the German academic and research sector, making it a point of interest for mapping institutional internet resources.
Changes in the center's registry status or the appearance of announced prefixes would signal shifts in its network operations, connectivity, or exposure. As a biomedical research hub, any network activation could affect dependency chains within the German academic and research sector, making it a point of interest for mapping institutional internet resources.
The center is visible in global internet resource registries through its ASN, but it does not currently advertise any IP prefixes. Its network operating role is therefore inactive or operated behind transit, making the registry entry the primary public evidence of its potential for future routing activity.
If AS210482 begins announcing prefixes, the center would become an active routing entity, requiring reassessment of its upstream providers, security posture, and connectivity dependencies. Currently, the absence of prefixes itself signals that the ASN is held in reserve, and any change would directly impact how its network role is assessed.
The Max-Delbrueck Center for Molecular Medicine (MDC) is a research institute within the Helmholtz Association that also holds AS210482. Public PeeringDB and website evidence confirm the ASN registration, but no prefix announcements are observed, making its network role dormant. The primary significance lies in the potential for future routing activity, which would necessitate updated infrastructure risk and dependency assessments. Watchpoints include ASN status changes, new prefixes, and upstream provider disclosures. Current evidence is limited to the registry entry and the institute's own website, leaving its actual network integration and commercial contracts uncertain.
If AS210482 begins announcing prefixes, the center would become an active routing entity, requiring reassessment of its upstream providers, security posture, and connectivity dependencies. Currently, the absence of prefixes itself signals that the ASN is held in reserve, and any change would directly impact how its network role is assessed.
| 0.90–1.00 | A | High — direct sources |
| 0.75–0.89 | A/B | Strong |
| 0.55–0.74 | B/C | Medium |
| 0.35–0.54 | C/D | Weak–medium |
| 0.10–0.34 | D | Weak signal |
| 0.00–0.09 | D | Internal monitoring |
Several public sources
亥姆霍兹联合会马克斯·德尔布吕克分子医学中心
亥姆霍兹联合会马克斯·德尔布吕克分子医学中心 (MDC) 是一家德国生物医学研究机构，拥有自治系统号 AS210482。公开记录确认了该 ASN 的注册，但当前没有已通告的路由前缀，表明该网络处于休眠状态，未来可能转为活跃，值得基础设施分析师加以监控。 另见: Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft.
为何重要
如果 AS210482 开始通告路由前缀，该中心将成为一个活跃的路由实体，从而需要重新评估其上游提供商、安全态势和连接依赖性。目前，缺少前缀本身就表明该 ASN 处于保留状态，任何变化都将直接影响对其网络角色的评估。 另见: FR-GAMMICCHIAMA-20260516 GAMMICCHIA Matt 以 NET2LAN 名义经营.
公开来源显示的情况
亥姆霍兹联合会马克斯·德尔布吕克分子医学中心 (MDC) 是一家德国生物医学研究机构，在全球互联网注册机构中显示为自治系统 AS210482 的持有者。公开记录确认了该 ASN 的分配，但当前没有来自该网络的 IP 前缀通告，使其在互联网上的运营角色实际上处于休眠状态。 另见: cve.
对于基础设施分析师而言，休眠的 ASN 代表着一种潜伏资产，可能突然转为活跃，从而产生新的依赖关系和潜在的安全暴露面。MDC 作为一家拥有基因组、临床和分子等高价值数据的主要研究中心，其网络的任何激活都可能影响德国学术和科研领域内的连通性。 另见: Arseniy Likhacev.
PeeringDB 上 AS210482 的 API 将 MDC 列为网络运营商，该中心的官方网站 mdc-berlin.de 确认了其机构身份以及其在亥姆霍兹联合会的成员资格。除这些来源外，没有可用的公开路由数据或上游提供商合同，因此评估仅限于注册信息层面。 另见: MOONYHOST-NET Gabriel Engvall.
目前，可核查的运作层面包括 ASN 注册信息、其在各注册机构的状态以及该机构的网站。没有证据表明存在直接对等互联、转接服务购买或客户网络。该机构的网络能力可能完全为内部使用，或通过 DFN（德国国家研究与教育网络）等上级研究网络进行代理。 另见: Letiste Praha, a. s..
主要的观察点是该 ASN 的路由前缀通告是否发生变化。全球路由表中若突然出现前缀，将把 MDC 从一个被动实体转变为主动网络运营商，从而需要立刻重新评估其上游依赖和路由安全态势。同样，注册信息的联系人信息或 PeeringDB 条目的更改也可能标志着网络管理的转变。 另见: 格雷肖特吉比特有限公司.
由于公开证据仅限于注册信息和机构网站，MDC 互联网网络的真实状态仍不确定。该 ASN 可能是一个遗留的预留资源、用于未来研究项目的预备资源，或是一个在转接提供商之后活跃但不对外通告的内部网络。在没有合同、路由数据或中心自身 IT 信息披露的情况下，评估必须保持保守。 另见: DSP_Loiret LOIRET FIBRE SAS.
可观察的运作层面
该中心通过其 ASN 在全球互联网资源注册机构中有所体现，但当前并未通告任何 IP 前缀。因此，其网络运营角色处于非活跃状态，或在转接服务之后运作，使得注册信息成为其未来可能开展路由活动的主要公开证据。
该中心注册状态的变化或路由前缀的出现，将标志着其网络运营、连接性或暴露面的转变。作为一家生物医学研究中心，任何网络激活行为都可能影响德国学术和科研领域内的依赖链，使其成为绘制机构互联网资源图景的关注点。
观察点
该中心虽有 ASN 注册但未通告前缀，这表明该网络资源要么是一个预备资产，要么在转接提供商之后使用，可能用于内部科研网络。对分析师来说，休眠的 AS 降低了即时风险，但仍是一种可能突然活跃的潜在资产，可能使德国科研领域的路由安全格局复杂化。
监控 PeeringDB 和 RIPE 注册数据库中 AS210482 状态的任何变化、新的前缀通告或中心公开网络联系信息的更新。同时跟踪中心可能要求直接互联网连接的机构合作伙伴关系，例如生物医学领域的大规模数据共享计划。
由于缺乏直接的路由数据和上游提供商披露，无法评估该 AS 是用于内部对等还是确实处于休眠状态。需要中心 IT 部门的官方文档或互联网服务合同来确认运营状态。
来源
- PeeringDB 网络资料 - 亥姆霍兹联合会马克斯·德尔布吕克分子医学中心的公开来源身份与注册上下文。
- 运营商网站 - 亥姆霍兹联合会马克斯·德尔布吕克分子医学中心的公开身份上下文。
Domain of operation
The Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft is a German biomedical research institute that holds Autonomous System 210482. Public records confirm the ASN registration but no current announced prefixes, indicating a dormant network presence that may become active, warranting monitoring by infrastructure analysts.
- PeeringDB network profile: public-source identity and registry context for Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft. Evidence basis: source-7401572d04f4
Timeline
- Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft public evidence observed
Changes in the center's registry status or the appearance of announced prefixes would signal shifts in its network operations, connectivity, or exposure. As a biomedical research hub, any network activation could affect dependency chains within the German academic and research sector, making it a point of interest for mapping institutional internet resources.
At A Glance
- Name: Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft
- Type: Network-related institution
- Base: Germany
- Profile focus: Institution
What It Does
- public operating records
- official service pages
- documented relationships updates
Why It Matters
- If AS210482 begins announcing prefixes, the center would become an active routing entity, requiring reassessment of its upstream providers, security posture, and connectivity dependencies. Currently, the absence of prefixes itself signals that the ASN is held in reserve, and any change would directly impact how its network role is assessed.
- Operational criticality: Medium
- Time horizon: Next quarter
What To Watch
- official company sources
- public registries
- operator-published records
Track verified source updates, role changes, and current public evidence.
If AS210482 begins announcing prefixes, the center would become an active routing entity, requiring reassessment of its upstream providers, security posture, and connectivity dependencies. Currently, the absence of prefixes itself signals that the ASN is held in reserve, and any change would directly impact how its network role is assessed.
Longer-term relevance depends on verified operating, policy, and relationship changes.
Member Briefing
Deeper Profile Context
Login is required to unlock the full profile briefing and source notes.
Only for Strategy Circle
Strategic Circle Access
Open to all readers. Unlock profile briefings after joining and logging in.
Join Strategic CircleOnly for Leadership Alliance
Leadership Alliance Access
For owners and management of IP-holding companies. Login required to unlock.
Join Leadership AlliancePublic View
If AS210482 begins announcing prefixes, the center would become an active routing entity, requiring reassessment of its upstream providers, security posture, and connectivity dependencies. Currently, the absence of prefixes itself signals that the ASN is held in reserve, and any change would directly impact how its network role is assessed.
Watchpoints
- The center's ASN registration without advertised prefixes suggests that the network resource is either a staging asset or is used behind a transit provider, perhaps for internal research networks.
- For an analyst, the dormant AS reduces immediate risk but remains a latent asset that could suddenly become active, potentially complicating the routing security landscape of the German research sector.
- Monitor PeeringDB and the RIPE Registry for any change in AS210482 status, new prefix announcements, or updates to the center's public network contact.
Caveats
- Public evidence is used only for source-backed claims.
- Private control or contract claims require separate public support.
FAQ
Why does BTW track Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft?
Changes in the center's registry status or the appearance of announced prefixes would signal shifts in its network operations, connectivity, or exposure. As a biomedical research hub, any network activation could affect dependency chains within the German academic and research sector, making it a point of interest for mapping institutional internet resources.
What evidence supports the profile?
public-source identity and registry context for Max-Delbrueck-Centrum fuer Molekulare Medizin in der Helmholtz-Gemeinschaft.
What should readers watch next?
The center's ASN registration without advertised prefixes suggests that the network resource is either a staging asset or is used behind a transit provider, perhaps for internal research networks.
